1st Bio

Developer of therapies for treating neurodegenerative and immuno-oncology diseases

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 2016 groups34 employees language 1stbio.com

Registered entities

Investor mix

20 investors on record; lead investors include Smile Gate Investment.

Investor typeCountShare
Venture capital1050%
Private equity315%
Bank & private debt315%
Other / undisclosed420%
Coming soon